Furosemide stimulates K transport in HCD57 erythroid cells

• Published in: The Journal of membrane biology Vol. 175; no. 3; pp. 235 - 244
• Main Authors: Kim, H D, Turner, J T, Burnett, J E, Joo, N S, Han, B H, Lim, R W, Bowen, J W, Kirk, R G, Lee, P
• Format: Journal Article
• Language: English
• Published: United States 01-06-2000
• Subjects: Animals; Biological Transport - drug effects; Carrier Proteins - genetics; Chlorides - metabolism; Culture Media - pharmacology; Dose-Response Relationship, Drug; Furosemide - pharmacology; K Cl- Cotransporters; Leukemia, Erythroblastic, Acute; Mice; Potassium - metabolism; Rats; Serum Albumin, Bovine - pharmacology; Symporters; Tumor Cells, Cultured
• ISSN: 0022-2631; 1432-1424
• DOI: 10.1007/s002320001071

We examined the influence of serum and furosemide on K movement and cell volume in HCD57 cells, a murine erythroleukemia cell line, which require erythropoietin (EPO) for survival. We found that maintenance of cell volume depends on the concentration of serum in the culture medium. In isotonic medium containing 20% serum, HCD57 cells maintain their steady-state volume. In contrast, the cells shrink progressively as medium serum content is reduced. In serum-free medium, raising external K to 75 mm prevents cell shrinkage and a further increase in K to 145 mm results in swelling, revealing a role for K permeability in the regulation of cell volume. Of particular interest has been a serendipitous finding with furosemide. Below an external K concentration of 2.1 +/- 0.3 mm in medium containing 2% serum, furosemide inhibits K uptake, probably stemming from its well known inhibitory action on KCl cotransport. However, above that K concentration, furosemide stimulates K uptake in a dose-dependent manner. Moreover, furosemide potentiates cell shrinkage induced by serum withdrawal. These findings suggest that the transport machinery mediating cellular shrinkage, once primed by serum depletion, becomes receptive to a second stimulus.